Search…

WuXi Biologics (02269.HK) raises its full-year revenue guidance for 2025 to 14-16%!

19/08/2025

According to Wisdom Finance APP, WuXi Biologics (02269.HK) has just announced in its 2025 mid-term performance report that it has revised its full-year revenue guidance for 2025 from 12%-15% to 14%-16%.

Latest

6 m ago

The Nasdaq Golden Dragon China Index experienced a wave of decline, falling more than 0.5% at one point, hitting a new daily low and approaching the 7600 point mark.

6 m ago

Canadian mineral exploration company Fjordland Exploration announced the appointment of Elyssia Patterson as Chief Financial Officer, replacing the resigning Mark Brown.

7 m ago

The price of natural gas futures in the United States fell more than 5%, hitting a nine-month low, due to record production levels, adequate fuel inventory, and weather forecasts showing that temperatures will not be as hot.

8 m ago

Fonterra: The Global Dairy Trade auction price index dropped by 0.3% on August 19, with the average price for milk powder contracts at FAS auctions being $4,291 per ton. The wholesale milk powder price index rose by 0.3% to $4,036 per ton.

10 m ago

U.S. stock market fluctuations | New Oriental (EDU.US) drops more than 2%, CEO Yu Minhong releases video to dispel rumors

+852 - 60190728

Customer Support

Commercial Services